Literature DB >> 17195072

FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies.

Sandip Basu, Abass Alavi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17195072     DOI： 10.1007/s00259-006-0313-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  8 in total

Review 1.  Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.

Authors:  Yusuf Menda; Michael M Graham
Journal:  Semin Nucl Med       Date:  2005-10       Impact factor: 4.446

2.  Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.

Authors:  Jørgen Johansen; Annika Eigtved; Christian Buchwald; Sune A Theilgaard; Hanne S Hansen
Journal:  Laryngoscope       Date:  2002-11       Impact factor: 3.325

Review 3.  Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple?

Authors:  C Nieder; V Gregoire; K K Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-07-01       Impact factor: 7.038

4.  Unknown primary tumors: detection with dual-modality PET/CT--initial experience.

Authors:  Andreas Gutzeit; Gerald Antoch; Hilmar Kühl; Thomas Egelhof; Markus Fischer; Elke Hauth; Susanne Goehde; Andreas Bockisch; Jörg Debatin; Lutz Freudenberg
Journal:  Radiology       Date:  2004-11-24       Impact factor: 11.105

Review 5.  The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.

Authors:  Kyle E Rusthoven; Mary Koshy; Arnold C Paulino
Journal:  Cancer       Date:  2004-12-01       Impact factor: 6.860

6.  Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.

Authors:  Gerreke Regelink; Jolijn Brouwer; Remco de Bree; Jan Pruim; Bernard F A M van der Laan; Willem Vaalburg; Otto S Hoekstra; Emile F I Comans; Arjan Vissink; C René Leemans; Jan L N Roodenburg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-05-04       Impact factor: 9.236

Review 7.  Positron emission imaging of head and neck cancer, including thyroid carcinoma.

Authors:  Heiko Schöder; Henry W D Yeung
Journal:  Semin Nucl Med       Date:  2004-07       Impact factor: 4.446

8.  The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor.

Authors:  Gerald B Fogarty; Lester J Peters; Josephine Stewart; Clare Scott; Danny Rischin; Rodney J Hicks
Journal:  Head Neck       Date:  2003-02       Impact factor: 3.147
  8 in total
  3 in total

1.  Utility of F-18 fluorodeoxyglucose posıtron emıssıon tomography/computed ın carcınoma of unknown primary.

Authors:  Umut Elboga; Selim Kervancioğlu; Ertan Sahin; Mustafa Basibuyuk; Y Zeki Celen; Cumali Aktolun
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

2.  Diagnostic Value of 18F-FDG PET/CT in Patients with Carcinoma of Unknown Primary

Authors:  Arzu Cengiz; Sibel Göksel; Yakup Yürekli
Journal:  Mol Imaging Radionucl Ther       Date:  2018-10-09

Review 3.  FDG PET/CT in carcinoma of unknown primary.

Authors:  Thomas C Kwee; Sandip Basu; Gang Cheng; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-31       Impact factor: 9.236
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.